BridgeBio Pharma gets FDA NDA acceptance for infigratinib
- FDA accepted NDA for infigratinib with Priority Review
- PDUFA target action date is February 4, 2027
- PROPEL 3 trial showed significant efficacy in achondroplasia
BBIO
BridgeBio Pharma, Inc. SEC filings
Every EDGAR filing for BridgeBio Pharma, Inc. (BBIO), newest first, with AI summaries and stories.
- Ticker
- BBIO
- CIK
- 1743881
- Sector
- Biotech and pharma
- Latest filing
- 6d
Next: earnings expected ~Nov 3 · 10-Q expected ~Nov 3 (deadline Nov 9)
Insider activity
No open-market insider buys in the last 30 days.
Also: 2 open-market sales ($691K).
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KBridgeBio Pharma, Inc.BBIOLIVE ROUTINE4BridgeBio Pharma, Inc.BBIOLIVE Neil Kumar, insider filing for BBIO
Neil Kumar, reporting
ROUTINE8-KBridgeBio Pharma, Inc.BBIOLIVE ROUTINE4BridgeBio Pharma, Inc.BBIOLIVE Neil Kumar, insider filing for BBIO
Neil Kumar, reporting
ROUTINE144BridgeBio Pharma, Inc.BBIOLIVE Neil Kumar, planned sale of BBIO shares
Neil Kumar, reporting
ROUTINE4BridgeBio Pharma, Inc.BBIOLIVE 3 insider filings
Thomas Trimarchi, insider filing for BBIO
Show all 3
- 4Insider filing for BBIO
- 4Insider filing for BBIO
- 4Insider filing for BBIO
Thomas Trimarchi, reporting
ROUTINE144BridgeBio Pharma, Inc.BBIOLIVE Neil Kumar, planned sale of BBIO shares
Neil Kumar, reporting
NOTABLESCHEDULE 13D/ABridgeBio Pharma, Inc.BBIOLIVE Ownership stake disclosure by KKR Genetic Disorder L.P. (amended)
KKR Genetic Disorder L.P., filed by
ROUTINE144BridgeBio Pharma, Inc.BBIOLIVE Randal W. Scott, planned sale of BBIO shares
Randal W. Scott, reporting
ROUTINE8-KBridgeBio Pharma, Inc.BBIOLIVE ROUTINE424B7BridgeBio Pharma, Inc.BBIOLIVE NOTABLE10-QBridgeBio Pharma, Inc.BBIOLIVE ROUTINE8-KBridgeBio Pharma, Inc.BBIOLIVE ROUTINE4BridgeBio Pharma, Inc.BBIOLIVE Maricel Apuli, insider filing for BBIO
Maricel Apuli, reporting
ROUTINESCHEDULE 13G/ABridgeBio Pharma, Inc.BBIOLIVE Ownership stake disclosure by FARALLON CAPITAL MANAGEMENT, L.L.C. (amended)
FARALLON CAPITAL MANAGEMENT, L.L.C., filed by
ROUTINESCHEDULE 13G/ABridgeBio Pharma, Inc.BBIOLIVE Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
ROUTINES-3ASRBridgeBio Pharma, Inc.BBIOLIVE ROUTINES-8BridgeBio Pharma, Inc.BBIOLIVE ROUTINE8-KBridgeBio Pharma, Inc.BBIOLIVE ROUTINE4BridgeBio Pharma, Inc.BBIOLIVE 2 insider filings
Andrea Ellis, insider filing for BBIO
Show all 2
- 4Insider filing for BBIO
- 4Insider filing for BBIO
Andrea Ellis, reporting
NOTABLESCHEDULE 13D/ABridgeBio Pharma, Inc.BBIOLIVE Ownership stake disclosure by VIKING GLOBAL INVESTORS LP (amended)
VIKING GLOBAL INVESTORS LP, filed by
ROUTINE144BridgeBio Pharma, Inc.BBIOLIVE 2 Form 144 notices
Jennifer E. Cook, planned sale of BBIO shares
Show all 2
- 144Planned insider sale of BBIO shares
- 144Planned insider sale of BBIO shares
Jennifer E. Cook, reporting
ROUTINE8-KBridgeBio Pharma, Inc.BBIOLIVE ROUTINE8-KBridgeBio Pharma, Inc.BBIOLIVE ROUTINE4BridgeBio Pharma, Inc.BBIOLIVE 12 insider filings
Jennifer E. Cook, insider filing for BBIO
Show all 12
- 4Insider filing for BBIO
- 4Insider filing for BBIO
- 4Insider filing for BBIO
- 4Insider filing for BBIO
- 4Insider filing for BBIO
- 4Insider filing for BBIO
- 4Insider filing for BBIO
- 4Insider filing for BBIO
- 4Insider filing for BBIO
- 4Insider filing for BBIO
- 4Insider filing for BBIO
- 4Insider filing for BBIO
Jennifer E. Cook, reporting
ROUTINE144BridgeBio Pharma, Inc.BBIOLIVE 2 Form 144 notices
Randal W. Scott, planned sale of BBIO shares
Show all 2
- 144Planned insider sale of BBIO shares
- 144Planned insider sale of BBIO shares
Randal W. Scott, reporting
ROUTINE4BridgeBio Pharma, Inc.BBIOLIVE Charles J Homcy, insider filing for BBIO
Charles J Homcy, reporting
ROUTINE144BridgeBio Pharma, Inc.BBIOLIVE 2 Form 144 notices
Jennifer E. Cook, planned sale of BBIO shares
Show all 2
- 144Planned insider sale of BBIO shares
- 144Planned insider sale of BBIO shares
Jennifer E. Cook, reporting
ROUTINE144BridgeBio Pharma, Inc.BBIOLIVE Hannah Valantine, planned sale of BBIO shares
Hannah Valantine, reporting
ROUTINE4BridgeBio Pharma, Inc.BBIOLIVE Jennifer E. Cook, insider filing for BBIO
Jennifer E. Cook, reporting
ROUTINE144BridgeBio Pharma, Inc.BBIOLIVE Jennifer E. Cook, planned sale of BBIO shares
Jennifer E. Cook, reporting
ROUTINE4BridgeBio Pharma, Inc.BBIOLIVE Neil Kumar, insider filing for BBIO
Neil Kumar, reporting
ROUTINESCHEDULE 13GBridgeBio Pharma, Inc.BBIOLIVE Ownership stake disclosure by Farallon Capital Partners, L.P.
Farallon Capital Partners, L.P., filed by